Skip to content

Trevi Therapeutics

US · TRVI #2810 by market cap Listed 2019
13.35 -0.37 -2.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 7 analysts

Buy
Avg price target 27.71 +107.6%
Price target rangecurrent 13.35
Low23.00
Avg27.71
High36.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 JonesTrading -- Buy 28.00
2026-11-10 Morgan Stanley -- Buy 23.00
2026-11-10 Stifel -- Buy 30.00
2026-11-10 Needham -- Buy 23.00
2026-11-10 BMO Capital -- Buy 36.00
2026-11-10 H.C. Wainwright -- Buy 24.00
2026-11-09 Cantor Fitzgerald -- Buy 30.00
2026-10-22 JonesTrading -- Buy 28.00
2026-10-06 BMO Capital -- Buy 36.00
2026-09-21 H.C. Wainwright -- Buy 24.00
2026-08-13 JonesTrading -- Buy 28.00
2026-08-11 H.C. Wainwright -- Buy 24.00
2026-08-10 Morgan Stanley -- Buy 23.00
2026-08-07 Raymond James -- Buy 40.00
2026-08-07 Morgan Stanley -- Buy 23.00
2026-08-07 Stifel -- Buy 30.00
2026-08-07 Needham -- Buy 23.00
2026-08-07 B. Riley Securities -- Buy 31.00
2026-08-07 Oppenheimer -- Buy 25.00
2026-08-06 Cantor Fitzgerald -- Buy 30.00
2026-07-21 BMO Capital -- Buy 36.00
2026-07-20 H.C. Wainwright -- Buy 24.00
2026-07-17 Morgan Stanley -- Buy 20.00
2026-07-17 Needham -- Buy 23.00
2026-05-20 Needham -- Buy 23.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-09 After close -- -2.61%
2026/Q2 2026-08-06 After close ±13.26% +0.05% (in line)
2026/Q1 2026-05-05 After close ±8.34% -2.73% (in line)
2025/Q4 2026-03-17 After close ±13.85% -4.47% (in line)
2025/Q3 2025-11-13 After close ±11.94% -0.79% (in line)
2025/Q2 2025-08-07 After close ±12.96% +1.64% (in line)
2025/Q1 2025-05-08 After close ±14.41% +0.00% (in line)
2024/Q4 2025-03-18 After close ±15.34% +3.81% (in line)
2024/Q3 2024-11-06 After close -- -6.45%
2024/Q2 2024-08-08 After close -- +2.14%
2024/Q1 2024-05-07 After close ±37.93% -8.97% (in line)
2023/Q4 2024-03-20 After close -- +4.52%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Trevi Therapeutics discussion 0 comments

Add a comment